By evaluating their association with clinical parameters and post-operative outcomes, we seek to determine whether the combined assessment of preoperative SII + Ki-67 index can improve the accuracy of predicting prognosis and improve risk stratification in PCa patients. The gene discussed is MKI67; the disease is posterior cortical atrophy.